SCLX: Scilex Holding Co. Consensus Target

Corporate company logo of Scilex Holding (SCLX)

Scilex Holding Company (SCLX) specializes in developing non-opioid treatments for chronic pain, offering safe patches and ointments. This price action chart confirms the company's market position, where the current metric stands at 392.63. Revenue is based on the sale of approved drugs, although the stability of these flows depends on competition. Environmental policy relies on the proper recycling of laboratory waste and initial steps toward decarbonization.

Scilex Holding - SCLX Consensus Target (period 04/28/2023 - 11/16/2026)

Analytical breakdowns for Scilex Holding (SCLX)

- price and consensus price forecast:
Summary company analytics:SCLX Scilex Holding
Manufactured products of Scilex

To find fundamental support for Scilex Holding Company (SCLX), it is essential to evaluate how scaling the distribution of non-opioid patches through existing channels expands margins despite the debt load. The current consensus price target aggregates the weighted average expectations of analysts, promptly reflecting the impact of cost inflation on the asset's value and signaling the business's degree of resilience to external shocks.

Competitors of Scilex Holding Company

Price Target Chart BIIB (Biogen)|Analyst Consensus Forecast NBIX (Neurocrine Biosciences Inc)|Analyst Target Range Regencell|AXSM - Price Target Chart|ACAD - Analyst Consensus Forecast|XENE: Analyst Consensus Forecast|Broker Consensus Forecast VKTX|Price Target Chart Supernus Pharmaceuticals|Broker Consensus Forecast CPRX (Catalyst Pharmaceuticals Inc)|Analyst Consensus Forecast DNLI|HRMY - Average Forecast Price|biohavenpharma.com - Consensus Target|Analyst Consensus Forecast Amylyx Pharmaceuticals Inc AMLX|TRVI - Price Target Chart|Fair Value Consensus PRAX (Praxis Corp)|Anavex (AVXL) - Price Target Chart|Average Forecast Price CeriBell, Inc. (CBLL)|Price Target Chart Prothena Corporation plc|Analyst Consensus Forecast alector.com|Price Target Chart Annexon, Inc. (ANNX)|Consensus Target Omeros OMER|Neurogene Therapeutics - Consensus Target|Fair Value Consensus ACIU|voyagertherapeutics.com - Analyst Consensus Forecast|Neumora (NMRA) - Consensus Target|TVGN: Analyst Consensus Forecast|Alpha Cognition (ACOG) - Analyst Consensus Forecast|Consensus Target CGTX|Analyst Consensus Forecast Inhibikase Therapeutics|Analyst Consensus Forecast SAVA|Analyst Median Target Assertio Holdings|Analyst Consensus Forecast COYA (Coya Therapeutics)|VTGN: Broker Consensus Forecast|OVID - Price Target Chart|Fair Value Consensus ABOS (Acumen Pharmaceuticals)|CRVO: Analyst Consensus Forecast|ATHE: Analyst Forecast Prices|CLNN (clene.com) - Analyst Consensus Forecast|pepgen.com (PEPG) - Analyst Median Target|Price Target Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Fair Value Consensus|Analyst Consensus Forecast ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Average Forecast Price|AIFF - Price Target Chart|anewmeds.com (KLTO) - Consensus Target|NeuroSense Therapeutics, Ltd. (NRSN) - Price Target Chart|Average Forecast Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Target Chart MetaVia|Broker Consensus Forecast NRXS (NeurAxis Inc.)|Analyst Consensus Forecast HSDT|PASG: Forecast Levels Chart|Neuphoria Therapeutics, Inc. - Consensus Target|NERV: Broker Consensus Forecast|athira.com - Analyst Consensus Forecast|ADXN - Analyst Consensus Forecast|ALZN: Analyst Consensus Forecast|CYCN - Analyst Median Target|PTIX (Protagenic Therapeutics, Inc.) - Analyst Consensus Forecast|pasitheaclinics.com (KTTA) - Analyst Median Target|Price Target Chart Cortigent Inc (CRGT)|Avenue Therapeutics, Inc. - Broker Consensus Forecast|Price Target Chart Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Consensus Target|chromocell.com - Analyst Consensus Forecast|Average Forecast Price Eliem Therapeutics, Inc.|ITCI: Analyst Consensus Forecast|LBPH - Analyst Median Target|Price Target Chart Marinus Pharmaceuticals|NKGN: Fair Value Consensus|Price Target Chart NeuroBo Pharmaceuticals Inc (NRBO)|Sage Therapeutics, Inc. - Broker Consensus Forecast|Synaptogenix, Inc - Consensus Target|Analyst Consensus Forecast Trevena, Inc TRVN|Vigil Neuroscience Inc. - Analyst Consensus Forecast|Average Forecast Price Anew Medical|CERE: Analyst Consensus Forecast